Published in Eur Heart J on December 23, 2013
Emergence of Nonobstructive Coronary Artery Disease: A Woman's Problem and Need for Change in Definition on Angiography. J Am Coll Cardiol (2015) 1.00
Cardiovascular Disease in Women: Clinical Perspectives. Circ Res (2016) 0.92
Coronary microvascular dysfunction, microvascular angina, and treatment strategies. JACC Cardiovasc Imaging (2015) 0.87
Recurrent Acute Nonrheumatic Streptococcal Myocarditis Mimicking STEMI in a Young Adult. Case Rep Cardiol (2014) 0.85
Coronary microcirculatory pathophysiology: can we afford it to remain a black box? Eur Heart J (2017) 0.82
Coronary Microvascular Function and Beyond: The Crosstalk between Hormones, Cytokines, and Neurotransmitters. Int J Endocrinol (2015) 0.80
Thrombus aspiration in acute myocardial infarction. Nat Rev Cardiol (2016) 0.78
The Challenges of Prevention, Diagnosis and Treatment of Ischemic Heart Disease in Women. Cardiovasc Drugs Ther (2015) 0.78
Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease. Circulation (2014) 0.78
Sex differences in the pathophysiology, treatment, and outcomes in IHD. Curr Atheroscler Rep (2015) 0.78
Targeting the dominant mechanism of coronary microvascular dysfunction with intracoronary physiology tests. Int J Cardiovasc Imaging (2017) 0.78
Elevated blood viscosity is associated with cerebral small vessel disease in patients with acute ischemic stroke. BMC Neurol (2017) 0.77
Cardiac energetics, oxygenation, and perfusion during increased workload in patients with type 2 diabetes mellitus. Eur Heart J (2015) 0.77
Coronary microvascular dysfunction: sex-specific risk, diagnosis, and therapy. Nat Rev Cardiol (2015) 0.77
Adverse Pregnancy Conditions, Infertility, and Future Cardiovascular Risk: Implications for Mother and Child. Cardiovasc Drugs Ther (2015) 0.77
Imaging oxygen metabolism with hyperpolarized magnetic resonance: a novel approach for cardiac and renal function assessement. Biosci Rep (2016) 0.75
A rare cause of chest pain in a cancer patient. J Community Hosp Intern Med Perspect (2016) 0.75
Evolution of Coronary Flow in an Experimental Slow Flow Model in Swines: Angiographic and Pathological Insights. Biomed Res Int (2015) 0.75
Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade. Circulation (2017) 0.75
Can improvements in our physiological understanding yield information on the utility of endothelial progenitor cell capture stents? Korean J Intern Med (2014) 0.75
Coronary flow velocity reserve by echocardiography: feasibility, reproducibility and agreement with PET in overweight and obese patients with stable and revascularized coronary artery disease. Cardiovasc Ultrasound (2016) 0.75
Invasive minimal Microvascular Resistance Is a New Index to Assess Microcirculatory Function Independent of Obstructive Coronary Artery Disease. J Am Heart Assoc (2016) 0.75
Global Coronary Artery Plaque Area is Associated with Myocardial Hypoperfusion in Women with Non-ST Elevation Myocardial Infarction. J Womens Health (Larchmt) (2015) 0.75
Contribution of KV1.5 Channel to H2O2-Induced Human Arteriolar Dilation and its Modulation by Coronary Artery Disease. Circ Res (2016) 0.75
Endocardial-epicardial distribution of myocardial perfusion reserve assessed by multidetector computed tomography in symptomatic patients without significant coronary artery disease: insights from the CORE320 multicentre study. Eur Heart J Cardiovasc Imaging (2015) 0.75
Obesity Related Coronary Microvascular Dysfunction: From Basic to Clinical Practice. Cardiol Res Pract (2016) 0.75
Left atrial enlargement increases the risk of major adverse cardiac events independent of coronary vasodilator capacity. Eur J Nucl Med Mol Imaging (2015) 0.75
Ketone Body Infusion With 3-Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study. J Am Heart Assoc (2017) 0.75
CYP2C19 variants and epoxyeicosatrienoic acids in patients with microvascular angina. Int J Cardiol Heart Vasc (2017) 0.75
Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet (2003) 19.90
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation (1986) 19.82
Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med (2008) 9.40
Low diagnostic yield of elective coronary angiography. N Engl J Med (2010) 9.38
Hypertrophic cardiomyopathy: a systematic review. JAMA (2002) 9.15
Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med (2013) 8.13
The inflammatory response in myocardial infarction. Cardiovasc Res (2002) 7.92
Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med (2008) 7.08
Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med (2002) 5.42
Coronary microvascular dysfunction. N Engl J Med (2007) 5.22
Nitric oxide synthases: regulation and function. Eur Heart J (2011) 4.71
Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials. Arch Intern Med (2012) 4.55
Postconditioning the human heart. Circulation (2005) 4.35
Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science (1993) 4.12
Intramyocardial, autologous CD34+ cell therapy for refractory angina. Circ Res (2011) 3.72
Myocardial no-reflow in humans. J Am Coll Cardiol (2009) 3.71
Aortic stenosis. Circulation (1968) 3.49
Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol (2006) 3.25
Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation (2006) 3.20
Angina with "normal" coronary arteries: a changing philosophy. JAMA (2005) 2.98
Relation between stress-induced myocardial perfusion defects on cardiovascular magnetic resonance and coronary microvascular dysfunction in patients with cardiac syndrome X. J Am Coll Cardiol (2008) 2.96
Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med (2003) 2.92
Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol (1995) 2.89
Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med (1994) 2.80
Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. J Am Coll Cardiol (2010) 2.68
Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) study. Eur Heart J (2006) 2.67
Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. N Engl J Med (2000) 2.57
Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol (2006) 2.57
Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction. J Am Coll Cardiol (2010) 2.54
Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. JACC Cardiovasc Imaging (2012) 2.53
"Microvascular angina" as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol (1988) 2.53
Women and ischemic heart disease: evolving knowledge. J Am Coll Cardiol (2009) 2.49
Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med (2009) 2.48
Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials. Lancet (2007) 2.48
Manual thrombus-aspiration improves myocardial reperfusion: the randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial. J Am Coll Cardiol (2005) 2.42
Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J (2011) 2.36
Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med (1993) 2.35
Thrombus aspiration before primary angioplasty improves myocardial reperfusion in acute myocardial infarction: the DEAR-MI (Dethrombosis to Enhance Acute Reperfusion in Myocardial Infarction) study. J Am Coll Cardiol (2006) 2.35
Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation (2004) 2.30
Early diagnosis of perioperative myocardial infarction after coronary bypass grafting: a study using biomarkers and cardiac magnetic resonance imaging. Ann Thorac Surg (2011) 2.27
High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries). J Am Coll Cardiol (2012) 2.24
Mechanisms of angina pectoris in syndrome X. J Am Coll Cardiol (1991) 2.16
Enhanced external counterpulsation is an effective treatment for Syndrome X. Int J Cardiol (2008) 2.15
Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Circulation (2004) 2.06
Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management. Circulation (2010) 2.03
Parvovirus B19 infection mimicking acute myocardial infarction. Circulation (2003) 2.03
Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans. Cardiovasc Res (2001) 1.89
Matching coronary blood flow to myocardial oxygen consumption. J Appl Physiol (1985) (2004) 1.83
Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms. Circulation (2004) 1.81
Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus. JACC Cardiovasc Imaging (2011) 1.75
Benefits of statin treatment in cardiac syndrome-X1. Eur Heart J (2003) 1.74
Decreased coronary reserve: a mechanism for angina pectoris in patients with aortic stenosis and normal coronary arteries. N Engl J Med (1982) 1.69
The case for myocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol (2009) 1.66
Long-term benefit of postconditioning. Circulation (2008) 1.65
Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2008): digest version. Circ J (2010) 1.63
Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol (2003) 1.61
Heterogeneity of microvascular dysfunction in women with chest pain not attributable to coronary artery disease: implications for clinical practice. Am Heart J (2003) 1.61
Role of adenosine in pathogenesis of anginal pain. Circulation (1990) 1.60
Relationship between postoperative cardiac troponin I levels and outcome of cardiac surgery. Circulation (2006) 1.60
Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation (2007) 1.54
Severity of coronary atherosclerosis in patients with a first acute coronary event: a diabetes paradox. Eur Heart J (2012) 1.54
Inflammatory mechanisms in myocardial infarction. Curr Drug Targets Inflamm Allergy (2003) 1.53
Effects of allopurinol on coronary microvascular and left ventricular function in patients with idiopathic dilated cardiomyopathy. Can J Cardiol (2012) 1.53
Rho-kinase: important new therapeutic target in cardiovascular diseases. Am J Physiol Heart Circ Physiol (2011) 1.50
Relationships between coronary flow vasodilator capacity and small artery remodelling in hypertensive patients. J Hypertens (2003) 1.49
Relation between cardiovascular risk factors and coronary microvascular dysfunction in cardiac syndrome X. J Cardiovasc Med (Hagerstown) (2011) 1.46
Improved exercise capacity with acute aminophylline administration in patients with syndrome X. J Am Coll Cardiol (1989) 1.46
Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position paper from the working group on coronary pathophysiology and microcirculation of the European Society of Cardiology. Cardiovasc Res (2010) 1.45
Esterified estrogens combined with methyltestosterone improve emotional well-being in postmenopausal women with chest pain and normal coronary angiograms. Menopause (2001) 1.45
Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. J Am Coll Cardiol (2009) 1.44
Angina with "normal" coronary arteries: sex differences in outcomes. Am Heart J (2007) 1.41
Myocardial perfusion in apical ballooning syndrome correlate of myocardial injury. Am Heart J (2006) 1.39
Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation (1995) 1.37
Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and angiographically normal coronary arteries. Circulation (2002) 1.36
Pathophysiological dilemma of syndrome X. Circulation (1992) 1.32
Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials. J Am Coll Cardiol (2007) 1.31
Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study. JACC Cardiovasc Interv (2012) 1.30
Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality. Am J Cardiol (2006) 1.26
Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm. J Am Coll Cardiol (2003) 1.25
Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis. Heart (2008) 1.24
C-reactive protein, clinical presentation, and ischemic activity in patients with chest pain and normal coronary angiograms. J Am Coll Cardiol (2003) 1.24
Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X. Am J Cardiol (2002) 1.24
Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory. Catheter Cardiovasc Interv (2008) 1.24
Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease. JACC Cardiovasc Imaging (2011) 1.23
Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction? Circulation (1993) 1.22
Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation (1994) 1.18
Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both? Eur Heart J (2007) 1.17
Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition. QJM (2009) 1.17
Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X. Am J Cardiol (1999) 1.15
Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography. Circulation (1995) 1.10
Cardiac syndrome X: a critical overview and future perspectives. Heart (2006) 1.08
Myocardial ischemia in women: lessons from the NHLBI WISE study. Clin Cardiol (2012) 1.07
Endothelial function and vascular response to mental stress are impaired in patients with apical ballooning syndrome. J Am Coll Cardiol (2010) 1.05
Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J (2005) 6.86
Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J (2006) 5.79
Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med (2003) 2.92
Myocardial oxygenation in coronary artery disease: insights from blood oxygen level-dependent magnetic resonance imaging at 3 tesla. J Am Coll Cardiol (2012) 2.38
Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol (2007) 2.22
Functional changes in coronary microcirculation after valve replacement in patients with aortic stenosis. Circulation (2003) 1.91
Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography/computed tomography. Eur Heart J (2011) 1.82
Myocardial blood flow measurement by PET: technical aspects and clinical applications. J Nucl Med (2005) 1.74
The case for myocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol (2009) 1.66
Myocardial glucose transport and utilization in patients with type 2 diabetes mellitus, left ventricular dysfunction, and coronary artery disease. J Am Coll Cardiol (2006) 1.65
Relationship between regional myocardial oxygenation and perfusion in patients with coronary artery disease: insights from cardiovascular magnetic resonance and positron emission tomography. Circ Cardiovasc Imaging (2009) 1.61
Systemic inhibition of nitric oxide synthase unmasks neural constraint of maximal myocardial blood flow in humans. Circulation (2004) 1.59
Absolute quantification of myocardial blood flow with H(2)(15)O and 3-dimensional PET: an experimental validation. J Nucl Med (2002) 1.57
Occurrence of regional left ventricular dysfunction in patients undergoing standard and biofeedback dialysis. Am J Kidney Dis (2006) 1.49
Pioglitazone improves myocardial blood flow and glucose utilization in nondiabetic patients with combined hyperlipidemia: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol (2007) 1.47
Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. J Am Coll Cardiol (2013) 1.44
Comparison of myocardial blood flow and coronary flow reserve during dobutamine and adenosine stress: Implications for pharmacologic stress testing in coronary artery disease. J Nucl Cardiol (2006) 1.39
Patent foramen ovale closure and brain ischaemic lesions. Heart (2013) 1.39
Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and angiographically normal coronary arteries. Circulation (2002) 1.36
Program of cell survival underlying human and experimental hibernating myocardium. Circ Res (2004) 1.27
Coronary microvascular resistance: methods for its quantification in humans. Basic Res Cardiol (2009) 1.26
Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction. Eur Heart J (2009) 1.26
Cardiac sympathetic imaging with mIBG in heart failure. JACC Cardiovasc Imaging (2010) 1.19
Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy. J Am Coll Cardiol (2006) 1.13
Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease. Eur Heart J (2009) 1.12
Respiratory gating of cardiac PET data in list-mode acquisition. Eur J Nucl Med Mol Imaging (2006) 1.10
Evaluation of the microcirculation in hypertension and cardiovascular disease. Eur Heart J (2007) 1.09
Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence. Eur Heart J (2012) 1.08
Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol (2007) 1.07
Can silent brain lesions be a target to guide anticoagulation treatment in patients with low-risk atrial fibrillation to reduce cognitive impairment? J Am Coll Cardiol (2014) 1.06
Imaging of vascular inflammation with [11C]-PK11195 and positron emission tomography/computed tomography angiography. J Am Coll Cardiol (2010) 1.05
Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations. J Am Coll Cardiol (2011) 1.03
Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance. Diabetes (2002) 1.00
Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease. JACC Cardiovasc Imaging (2013) 0.97
Microvascular dysfunction, myocardial ischemia, and progression to heart failure in patients with hypertrophic cardiomyopathy. J Cardiovasc Transl Res (2009) 0.95
Abnormal myocardial presynaptic norepinephrine recycling in patients with Brugada syndrome. Circulation (2004) 0.93
[Percutaneous coronary interventions. Guidelines of the European Society of Cardiology-ESC]. Kardiol Pol (2005) 0.93
Assessment of myocardial ischaemia and viability: role of positron emission tomography. Eur Heart J (2010) 0.91
Absolute blood flow and oxygen consumption in stunned myocardium in patients with coronary artery disease. J Am Coll Cardiol (2002) 0.91
Spatial relationship between coronary microvascular dysfunction and delayed contrast enhancement in patients with hypertrophic cardiomyopathy. J Nucl Med (2008) 0.91
Quantification of subendocardial and subepicardial blood flow using 15O-labeled water and PET: experimental validation. J Nucl Med (2006) 0.91
Effect of repeated episodes of reversible myocardial ischemia on myocardial blood flow and function in humans. Am J Physiol Heart Circ Physiol (2002) 0.90
Tetrahydrobiopterin restores impaired coronary microvascular dysfunction in hypercholesterolaemia. Eur J Nucl Med Mol Imaging (2004) 0.90
Myocardial beta-adrenoceptor down-regulation early after infarction is associated with long-term incidence of congestive heart failure. Eur Heart J (2010) 0.90
Detection and quantification of large-vessel inflammation with 11C-(R)-PK11195 PET/CT. J Nucl Med (2010) 0.90
123I-mIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: design of two prospective multicenter international trials. J Nucl Cardiol (2009) 0.89
Myocardial beta-adrenoceptor density one month after acute myocardial infarction predicts left ventricular volumes at six months. J Am Coll Cardiol (2002) 0.89
Is there evidence supporting coronary revascularization in patients with left ventricular systolic dysfunction? Circ J (2010) 0.88
Measurement of ventricular volumes and function: a comparison of gated PET and cardiovascular magnetic resonance. J Nucl Med (2002) 0.87
Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition. Int J Cardiol (2008) 0.86
Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans. Am J Physiol Endocrinol Metab (2002) 0.86
Myocardial pre-synaptic sympathetic function correlates with glucose uptake in the failing human heart. Eur J Nucl Med Mol Imaging (2007) 0.85
Perindopril and indapamide reverse coronary microvascular remodelling and improve flow in arterial hypertension. J Hypertens (2011) 0.84
Assessment of the long-term reproducibility of baseline and dobutamine-induced myocardial blood flow in patients with stable coronary artery disease. J Nucl Med (2005) 0.84
Immunocytochemical evidence for inducible nitric oxide synthase and cyclooxygenase-2 expression with nitrotyrosine formation in human hibernating myocardium. Basic Res Cardiol (2002) 0.83
Impairment of coronary flow reserve in aortic stenosis. J Appl Physiol (1985) (2008) 0.83
Pre- and post-synaptic sympathetic function in human hibernating myocardium. Eur J Nucl Med Mol Imaging (2007) 0.83
A novel (18)F-labeled tracer for the quantification of myocardial blood flow and infarct size with positron-emission tomography: another way to avoid the need of an on-site cyclotron. Circ Cardiovasc Imaging (2009) 0.82
Coronary microvascular dysfunction and ischemia in hypertrophic cardiomyopathy. Mechanisms and clinical consequences. Ital Heart J (2004) 0.82
Mapping genetic determinants of coronary microvascular remodeling in the spontaneously hypertensive rat. Basic Res Cardiol (2012) 0.82
Incidence of stunned, hibernating and scarred myocardium in ischaemic cardiomyopathy. Eur J Nucl Med Mol Imaging (2004) 0.82
Accuracy of PET in predicting functional recovery after revascularisation in patients with chronic ischaemic dysfunction: head-to-head comparison between blood flow, glucose utilisation and water-perfusable tissue fraction. Eur J Nucl Med Mol Imaging (2002) 0.82
Is central nervous system processing altered in patients with heart failure? Eur Heart J (2004) 0.81
Improvement of impaired coronary vasodilator reserve in hypertensive patients by low-dose ACE inhibitor/diuretic therapy: a pilot PET study. J Renin Angiotensin Aldosterone Syst (2003) 0.81
Hypertrophic cardiomyopathy: The need for randomized trials. Glob Cardiol Sci Pract (2013) 0.80
[Guidelines on the management of stable angina pectoris. Executive summary]. Rev Esp Cardiol (2006) 0.80
Effect of left ventricular assist device combination therapy on myocardial blood flow in patients with end-stage dilated cardiomyopathy. J Heart Lung Transplant (2004) 0.79
Is the chest pain in cardiac syndrome X due to subendocardial ischaemia? Eur Heart J (2007) 0.79
Methods to investigate coronary microvascular function in clinical practice. J Cardiovasc Med (Hagerstown) (2013) 0.79
Cardiac nociception. Circulation (2006) 0.78
Myocardial stunning is associated with impaired calcium uptake by sarcoplasmic reticulum. Biochem Biophys Res Commun (2009) 0.78
Assessment of infarct size by positron emission tomography and [18F]2-fluoro-2-deoxy-D-glucose: a new absolute threshold technique. Eur J Nucl Med Mol Imaging (2002) 0.78
Basal and hyperaemic myocardial blood flow in regionally denervated canine hearts: an in vivo study with positron emission tomography. Eur J Nucl Med Mol Imaging (2006) 0.78
Systemic nitric oxide synthase inhibition improves coronary flow reserve to adenosine in patients with significant stenoses. Am J Physiol Heart Circ Physiol (2007) 0.78
[Guidelines for percutaneous coronary interventions]. Rev Esp Cardiol (2005) 0.77
Relationship between atrial fibrillation and blunted hyperemic myocardial blood flow in patients with hypertrophic cardiomyopathy. J Nucl Cardiol (2009) 0.77
The blunting of coronary flow reserve in hypertension with left ventricular hypertrophy is transmural and correlates with systolic blood pressure. J Hypertens (2014) 0.77
Low frequency spectral component of heart rate variability and myocardial beta-adrenoceptor density after acute myocardial infarction. Basic Res Cardiol (2002) 0.77
Absolute figures are better than percentages. JACC Cardiovasc Imaging (2009) 0.77
Quantification of [11C]GB67 binding to cardiac alpha1-adrenoceptors with positron emission tomography: validation in pigs. Eur J Nucl Med Mol Imaging (2008) 0.77
[Guidelines on the management of stable angina pectoris; the experts of the European Society of Cardiology on the management of stable angina pectoris]. Kardiol Pol (2006) 0.77
[Guidelines for percutaneous coronary interventions]. Ital Heart J Suppl (2005) 0.77
Effects of long-term oral dipyridamole treatment on coronary microcirculatory function in patients with chronic stable angina: A substudy of the persantine in stable angina (PISA) study. J Cardiovasc Pharmacol (2006) 0.77
[Cardiac involvement at rest in patients with systemic sclerosis: differences between the limited and the diffuse form of the disease]. G Ital Cardiol (Rome) (2014) 0.76
Need for new non-invasive imaging strategies to identify high-risk asymptomatic patients with carotid stenosis. Int J Cardiol (2013) 0.76
Positron emission tomography for quantitation of myocardial perfusion. J Nucl Cardiol (2004) 0.76
Coronary microvascular dysfunction in patients with cardiomyopathies. Circ Heart Fail (2008) 0.76
From Left Ventricular Hypertrophy to Dysfunction and Failure. Circ J (2016) 0.76
Myocardial viability in ischemic left ventricular dysfunction. N Engl J Med (2011) 0.76
A critical reappraisal of differences in cardiac resynchronization therapy defibrillator effectiveness between men and women in the MADIT-CRT trial. J Am Coll Cardiol (2011) 0.75
Molecular imaging of vascular inflammation. Eur J Nucl Med Mol Imaging (2010) 0.75
Risk stratification of patients with normal myocardial perfusion imaging: help comes from the periphery. Eur Heart J (2013) 0.75
Myocardial ischaemia and metabolic memory. Eur J Nucl Med Mol Imaging (2006) 0.75
Calcified left ventricular endomyocardial fibrosis. J Heart Valve Dis (2012) 0.75
An accordion not to be played. J Cardiovasc Med (Hagerstown) (2017) 0.75
[An unusual case of transient ST-segment elevation during hypertensive crisis in a patient with left ventricular hypertrophy]. G Ital Cardiol (Rome) (2012) 0.75
Hibernation and congestive heart failure. Heart Fail Rev (2003) 0.75
[Revascularization of the hibernated myocardium: a clinical problem still unsolved]. G Ital Cardiol (Rome) (2012) 0.75
["African sickness" and the heart: the mystery of endomyocardial fibrosis]. G Ital Cardiol (Rome) (2011) 0.75
Is the chest pain in cardiac syndrome X due to subendocardial ischaemia? Ital Heart J (2002) 0.75